David Wessenberg
Analyst, Piper Sandler
Replay available
Adaptive Biotechnologies Corporation (ADPT) Q4 2025 Earnings Call
Adaptive Biotechnologies Corporation (NASDAQ: ADPT) Q4 2025 earnings conference call, held 2026-02-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Karina Calzadilla
Vice President, Investor Relations
Chad Robbins
Chief Executive Officer & Co-Founder
Kyle Tesco
Chief Financial Officer
Dan Brennan
Analyst, TD Cowen
Mark Massaro
Analyst, BTIG
Sebastian Sandler
Analyst, J.P. Morgan
Craig Howland
Analyst, Capital Group
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Adaptive Biotechnologies Corporation.
Replay transcript excerpt
WEBVTT 00:00:03.862 -- 00:00:08.487 Adaptive Biotechnology's fourth quarter and four-year earnings conference call. 00:00:08.487 -- 00:00:12.451 At this time, all participants are in a listen-only mode. 00:00:12.451 -- 00:00:16.836 After the speaker's presentation, there will be a question-and-answer session. 00:00:16.836 -- 00:00:21.261 To ask a question during the session, you will need to press star 1-1 on your telephone. 00:00:21.261 -- 00:00:25.445 You will then hear an automated message advising your hand is raised. 00:00:25.445 -- 00:00:28.488 To withdraw your question, please press star 1-1 again. 00:00:28.488 -- 00:00:29.930 Please 00:00:29.930 -- 00:00:33.764 be advised that today's conference is being recorded. 00:00:33.764 -- 00:00:39.109 I would now like to hand the conference over to your speaker today, Karina Calzadilla, 00:00:39.109 -- 00:00:43.171 Vice President, Investor Relations. Please go ahead. 00:00:43.533 -- 00:00:46.096 Thank you, Daniel, and good afternoon, everyone. 00:00:46.096 -- 00:00:49.960 I would like to welcome you to Adaptive Biotechnology's fourth quarter and full year 00:00:49.960 -- 00:00:55.145 2025 earnings conference call. Earlier today, we issued a press release reporting 00:00:55.145 -- 00:00:58.908 adaptive financial results for the fourth quarter and full year of 2025. 00:00:58.908 -- 00:01:02.910 The press release is available at www.adaptivebiotech.com. 00:01:04.223 -- 00:01:09.891 We are conducting a live webcast of these calls and will be referencing to a slide presentation 00:01:09.891 -- 00:01:14.577 that has been posted to the investor section in our corporate website. 00:01:14.577 -- 00:01:18.502 During the call, management will make projections and other forward-looking statements 00:01:18.502 -- 00:01:23.128 with...